-
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation
Frerichs, K. A., Verkleij, C. P. M., Mateos, M. V., Martin, T. G., Rodriguez, C., Nooka, A., Banerjee, A., Chastain, K., Perales-Puchalt, A., Stephenson, T., Uhlar, C., Kobos, R., van der Holt, B., Kruyswijk, S., Kuipers, M. T., Groen, K., Vishwamitra, D., Skerget, S., Cortes-Selva, D., Doyle, M., & 4 others , 9 Jan 2024, In: Blood. 8, 1, p. 194-206 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA
van de Donk, N. W. C. J., O’Neill, C., de Ruijter, M. E. M., Verkleij, C. P. M. & Zweegman, S., 1 Nov 2023, In: Current opinion in oncology. 35, 6, p. 601-611 11 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma
Verkleij, C. P. M., Frerichs, K. A., Broekmans, M. E. C., Duetz, C., O'Neill, C. A., Bruins, W. S. C., Homan-Weert, P. M., Minnema, M. C., Levin, M-D., Broijl, A., Bos, G. M. J., Kersten, M. J., Klein, S. K., Shikhagaie, M. M., Casneuf, T., Abraham, Y., Smets, T., Vanhoof, G., Cortes-Selva, D., van Steenbergen, L., & 7 others , 2 May 2023, In: HemaSphere. 7, 5, p. E881Research output: Contribution to journal › Article › Academic › peer-review
- All publications